My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 213

    1.

    Evidence against PALB2 involvement in Icelandic breast cancer susceptibility.

    Gunnarsson H, Arason A, Gillanders EM, Agnarsson BA, Johannesdottir G, Johannsson OT, Barkardottir RB.

    J Negat Results Biomed. 2008 Jul 17;7:5.PMID: 18637200 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Penetrance analysis of the PALB2 c.1592delT founder mutation.

    Erkko H, Dowty JG, Nikkilä J, Syrjäkoski K, Mannermaa A, Pylkäs K, Southey MC, Holli K, Kallioniemi A, Jukkola-Vuorinen A, Kataja V, Kosma VM, Xia B, Livingston DM, Winqvist R, Hopper JL.

    Clin Cancer Res. 2008 Jul 15;14(14):4667-71.PMID: 18628482 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.

    Heikkinen T, Kärkkäinen H, Aaltonen K, Milne RL, Heikkilä P, Aittomäki K, Blomqvist C, Nevanlinna H.

    Clin Cancer Res. 2009 May 1;15(9):3214-22. Epub 2009 Apr 21.PMID: 19383810 [PubMed - indexed for MEDLINE]Related articles

    4.

    A recurrent mutation in PALB2 in Finnish cancer families.

    Erkko H, Xia B, Nikkilä J, Schleutker J, Syrjäkoski K, Mannermaa A, Kallioniemi A, Pylkäs K, Karppinen SM, Rapakko K, Miron A, Sheng Q, Li G, Mattila H, Bell DW, Haber DA, Grip M, Reiman M, Jukkola-Vuorinen A, Mustonen A, Kere J, Aaltonen LA, Kosma VM, Kataja V, Soini Y, Drapkin RI, Livingston DM, Winqvist R.

    Nature. 2007 Mar 15;446(7133):316-9. Epub 2007 Feb 7.PMID: 17287723 [PubMed - indexed for MEDLINE]Related articles

    5.

    Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.

    García MJ, Fernández V, Osorio A, Barroso A, Llort G, Lázaro C, Blanco I, Caldés T, de la Hoya M, Ramón Y Cajal T, Alonso C, Tejada MI, San Román C, Robles-Díaz L, Urioste M, Benítez J.

    Breast Cancer Res Treat. 2009 Feb;113(3):545-51. Epub 2008 Feb 27.PMID: 18302019 [PubMed - indexed for MEDLINE]Related articles

    6.

    Analysis of PALB2/FANCN-associated breast cancer families.

    Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G, van Beers EH, Li L, Khalil T, Quenneville LA, Omeroglu A, Poll A, Lepage P, Wong N, Nederlof PM, Ashworth A, Tonin PN, Narod SA, Livingston DM, Foulkes WD.

    Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6788-93. Epub 2007 Apr 9.PMID: 17420451 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families.

    Pylkäs K, Erkko H, Nikkilä J, Sólyom S, Winqvist R.

    BMC Cancer. 2008 May 26;8:146.PMID: 18501021 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    PALB2 sequence variants in young South African breast cancer patients.

    Sluiter M, Mew S, van Rensburg EJ.

    Fam Cancer. 2009;8(4):347-53. Epub 2009 Mar 31.PMID: 19333784 [PubMed - indexed for MEDLINE]Related articles

    9.

    Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women.

    Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E, Robidoux A, Martin G, Bismar TA, Tischkowitz M, Rousseau F, Narod SA.

    Breast Cancer Res. 2007;9(6):R83.PMID: 18053174 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.

    Potapova A, Hoffman AM, Godwin AK, Al-Saleem T, Cairns P.

    Cancer Res. 2008 Feb 15;68(4):998-1002.PMID: 18281473 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.

    Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM.

    Breast Cancer Res Treat. 2009 Apr;114(3):457-62. Epub 2008 Apr 30.PMID: 18446436 [PubMed - indexed for MEDLINE]Related articles

    12.

    The BARD1 Cys557Ser variant and breast cancer risk in Iceland.

    Stacey SN, Sulem P, Johannsson OT, Helgason A, Gudmundsson J, Kostic JP, Kristjansson K, Jonsdottir T, Sigurdsson H, Hrafnkelsson J, Johannsson J, Sveinsson T, Myrdal G, Grimsson HN, Bergthorsson JT, Amundadottir LT, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K.

    PLoS Med. 2006 Jul;3(7):e217.PMID: 16768547 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

    Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, Jayatilake H, McGuffog L, Hanks S, Evans DG, Eccles D; Breast Cancer Susceptibility Collaboration (UK), Easton DF, Stratton MR.

    Nat Genet. 2007 Feb;39(2):165-7. Epub 2006 Dec 31.PMID: 17200668 [PubMed - indexed for MEDLINE]Related articles

    14.

    Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families.

    Guénard F, Labrie Y, Ouellette G, Joly Beauparlant C, Simard J, Durocher F; INHERIT BRCAs.

    J Hum Genet. 2008;53(7):579-91. Epub 2008 Apr 15.PMID: 18414782 [PubMed - indexed for MEDLINE]Related articles

    15.

    Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer.

    Tischkowitz M, Sabbaghian N, Ray AM, Lange EM, Foulkes WD, Cooney KA.

    Prostate. 2008 May 1;68(6):675-8.PMID: 18288683 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations.

    Kim JH, Choi DH, Cho DY, Ahn SH, Son BH, Haffty BG.

    Breast Cancer Res Treat. 2010 Mar 6. [Epub ahead of print]PMID: 20213081 [PubMed - as supplied by publisher]Related articles

    17.

    Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.

    Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, Wurm M, Batish SD, Lach FP, Yetgin S, Neitzel H, Ariffin H, Tischkowitz M, Mathew CG, Auerbach AD, Rahman N.

    Nat Genet. 2007 Feb;39(2):162-4. Epub 2006 Dec 31.PMID: 17200671 [PubMed - indexed for MEDLINE]Related articles

    18.

    Association of common PALB2 polymorphisms with breast cancer risk: a case-control study.

    Chen P, Liang J, Wang Z, Zhou X, Chen L, Li M, Xie D, Hu Z, Shen H, Wang H.

    Clin Cancer Res. 2008 Sep 15;14(18):5931-7.PMID: 18794107 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.

    Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW, Lin JC, Palmisano E, Brune K, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Parmigiani G, Kern SE, Velculescu VE, Kinzler KW, Vogelstein B, Eshleman JR, Goggins M, Klein AP.

    Science. 2009 Apr 10;324(5924):217. Epub 2009 Mar 5.PMID: 19264984 [PubMed - indexed for MEDLINE]Related articles

    20.

    Genetic predisposition to breast cancer: past, present, and future.

    Turnbull C, Rahman N.

    Annu Rev Genomics Hum Genet. 2008;9:321-45. Review.PMID: 18544032 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk